CNC
Centene Corp. · Healthcare · Medical - Healthcare Plans
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 169 | +2 | 380.11M | $24.37B | +5 | −2 |
| Q1 2026 | 169 | +4 | 362.48M | $11.86B | +7 | −4 |
| Q4 2025 | 164 | -1 | 388.17M | $15.98B | +2 | −2 |
| Q3 2025 | 26 | +2 | 229.56M | $8.20B | +3 | −2 |
| Q2 2025 | 22 | 0 | 267.14M | $14.49B | +2 | −2 |
| Q1 2025 | 19 | -1 | 141.75M | $8.61B | — | −1 |
| Q4 2024 | 20 | +1 | 155.02M | $9.39B | +2 | −1 |
| Q3 2024 | 18 | +2 | 123.00M | $9.25B | +3 | −1 |
| Q2 2024 | 16 | — | 123.78M | $8.20B | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Capital World Investors ✦ | 26.64M | — | $1.77B | 0.3% | n/c | 1 | SEC ↗ |
| 2 | Harris Associates (Oakmark) ✦ | 24.89M | — | $1.65B | 2.8% | n/c | 1 | SEC ↗ ×2 |
| 3 | Norges Bank ✦ (passive) | 21.21M | — | $1.41B | 0.2% | n/c | 1 | SEC ↗ |
| 4 | Wellington Management ✦ | 19.06M | — | $1.26B | 0.2% | n/c | 1 | SEC ↗ ×8 |
| 5 | Geode Capital Management ✦ (passive) | 12.68M | — | $839.02M | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 6 | Arrowstreet Capital ✦ | 8.04M | — | $533.10M | 0.5% | n/c | 1 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 4.46M | — | $295.80M | 0.5% | n/c | 1 | SEC ↗ ×5 |
| 8 | T. Rowe Price ✦ | 2.67M | — | $177.09M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 9 | Glenview Capital ✦ | 1.43M | — | $94.90M | 2.0% | n/c | 1 | SEC ↗ |
| 10 | Millennium Management ✦ | 632.16K | — | $41.91M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 534.23K | — | $35.42M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 12 | Adage Capital Partners ✦ | 456.91K | — | $30.29M | 0.1% | n/c | 1 | SEC ↗ |
| 13 | Bridgewater Associates ✦ | 444.00K | — | $29.44M | 0.2% | n/c | 1 | SEC ↗ |
| 14 | D. E. Shaw & Co. ✦ | 328.55K | — | $21.78M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 15 | Gotham Asset Management ✦ | 161.66K | — | $10.72M | 0.1% | n/c | 1 | SEC ↗ |
| 16 | Marshall Wace ✦ | 126.30K | — | $8.37M | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 856 holders, 470.26M shares, $14.63B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 56.50K sh · $3.78M
Officer · 47.60K sh · $3.11M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology